Bisphenol a impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth

IUBMB Life

Volumn 62, Issue 9, 2010, Pages 684-687

  Bolli, Alessandro ^a,b   Bulzomi, Pamela ^a   Galluzzo, Paola ^a   Acconcia, Filippo ^a   Marino, Maria ^a,b  

^a ROMA TRE UNIVERSITY   (Italy)

^b National Institute for Biostructures and Biosystems   (Italy)

Author keywords

17b estradiol; Apoptosis; Bisphenol A; Colon cancer cell line; Endocrine disruptor; Estrogen receptor b

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN RECEPTOR BETA; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CELL FUNCTION; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG RECEPTOR BINDING; ESTROGEN ACTIVITY; GENE ACTIVITY; HORMONE ACTION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ESTRADIOL ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; PHENOLS; PROTEIN BINDING;

EID: 78649745992     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.370     Document Type: Article

References (21)

1. Slattery, M. L., Kinney, A. Y., and Levin, T. R. (2004) Factors associated with colorectal cancer screening in a population-based study: The impact of gender, health care source, and time. Prev. Med. 38, 276-283.
2. DeCosse, J. J., Ngoi, S. S., Jacobson, J. S., and Cennerazzo, W. J. (1993) Gender and colorectal cancer. Eur. J. Cancer Prev. 2, 105-115.
3. Crandall, C. J. (1999) Estrogen replacement therapy and colon cancer: A clinical review. J. Womens Health Gend. Based Med. 8, 1155-1166.
4. Franceschi, S., Gallus, S., Salamini, R., Tafani, A., Negri, E., and La Vecchia, C. (2000) Menopause and colorectal cancer. Br. J. Cancer 82, 1860-1862.
5. Marino, M. and Galluzzo, P. (2008) Estrogen receptor b mediates the protective effects of estrogen in colon cancer. Cancer Ther. 6, 149-162.
6. Campbell-Thompson, M., Lynch, I. J., and Bhardwaj, B. (2001) Expression of estrogen receptor (ER) subtypes and ERb isoforms in colon cancer. Cancer Res. 61, 632-640.
7. Bardin, A., Boulle, N., Lazennec, G., Vignon, F., and Pujol, P. (2004) Loss of ERb expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer. 11, 537-551.
8. Foley, E. F., Jazaeri, A. A., Shupnik, M. A., Jazaeri, O., and Rice, L. W. (2000) Selective loss of estrogen receptor b in malignant human colon. Cancer Res. 60, 245-248.
9. Konstantinopoulos, P. A., Kominea, A., Vandoros, G., Sykiotis, G. P., Andricopoulos, P., Varakis, I., Sotiropoulou-Bonikou, G., and Papavassiliou, A. G. (2003) Oestrogen receptor beta (ERb) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiation. Eur. J. Cancer 39, 251-258.
10. Galluzzo, P., Caiazza, F., Moreno, S., and Marino, M. (2007) Role of ERb palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr. Relat. Cancer 14, 153-167.
11. Caiazza, F., Galluzzo, P., Lorenzetti, S., and Marino, M. (2007) 17b-estradiol induces ERb up-regulation via p38/MAPK activation in colon cancer cells. Biochem. Biophys. Res. Commun. 359, 102-107.
12. Ascenzi, P., Bocedi, A., and Marino, M. (2006) Structure-function relationship of estrogen receptor a and b: Impact on human health. Mol. Aspects Med. 27, 299-402.
13. Kuiper, G. G., Carlsson, B., Grandien, K., Enmark, E., Hägblad, J., Nilsson, S., and Gustafsson, J.-Å. . (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138, 863-870. (Pubitemid 27089735)
14. Wetherill, Y. B., Akingbemi, B. T., Kanno, J., McLachlan, J. A., Nadal, A., Sonnenschein, C., Watson, C. S., Zoeller, R. T., and Belcher, S. M. (2007) In vitro molecular mechanisms of bisphenol A action. Reprod. Toxicol. 24, 178-198.
15. Richter, C. A., Birnbaum, L. S., Farabollini, F., Newbold, R. R., Rubin, B. S., Talsness, C. E., Vandenbergh, J. G., Walser-Kuntz, D. R., and vom Saal, F. S. (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod. Toxicol. 24, 199-224.
16. Krishnan, A. V., Starhis, P., Permuth, S. F., Tokes, L., and Feldman, D. (1993) Bisphenol-A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132, 2279-2286.
17. Kurosawa, T., Hiroi, H., Tsutsumi, O., Ishikawa, T., Osuga, Y., Fujiwara, T., Inoue, S., Muramatsu, M., Momoeda, M., and Taketani, Y. (2002) The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocr. J. 49, 465-471.
18. Ricupito, A., Del Pozzo, G., Diano, N., Grano, V., Portaccio, M., Marino, M., Bolli, A., Galluzzo, P., Bontempo, P., Mita, L., Altucci, L., and Mita, D. G. (2009) Effect of bisphenol A with or without enzyme treatment on the proliferation and viability of MCF-7 cells. Environ. Int. 35, 21-26.
19. Bolli, A., Galluzzo, P., Ascenzi, P., Del Pozzo, G., Manco, I., Vietri, M. T., Mita, L., Altucci, L., Mita, D. G., and Marino, M. (2008) Laccase treatment impairs bisphenol A-induced cancer cell proliferation affecting estrogen receptor a-dependent rapid signals. IUBMB Life 60, 843-852.
20. Hess-Wilson, J. K., Webb, S. L., Daly, H. K., Leung, Y. K., Boldison, J., Comstock, C. E., Sartor, M. A., Ho, S. M., and Knudsen, K. E. (2007) Unique bisphenol A transcriptome in prostate cancer: novel effects on ERb expression that correspond to androgen receptor mutation status. Environ. Health Perspect. 115, 1646-1653.
21. Schults, J. R., Ruppel, P. I., and Johnson, M. A. (1988) Pharmaceutical lead discovery and optimization. In Biopharmaceutical Statistics for Drug Development. (Peace, K. E., ed.). Marcel Dekker, New York.